Albumin analyzers are lab instruments that finding increasing adoption for their function of detecting and testing the albumin content in body fluids, primarily to identify kidney damage, and creating interventional programs to cure or prevent the same.
The constant innovations in advanced technologies has resulted in the release of portable albumin analyzers that provide users with faster and more accurate rates of analysis. As a result of this, these machines are now easily available, in a diverse variety of configurations.
Increasing Simplicity and Faster Results Underline Development of New Products
As per a recent study by Future Market Insights on the global albumin analyzers market, the constantly rising incidences of kidney disease and growing awareness on the adverse effects of these health issues among patients and the healthcare community are boosting the requirement for faster, precise, and simplified tools that boost testing and detection of kidney health issues. This has defined the direction of development for albumin analyzer manufacturers, resulting in the development of automated and digital equipment.
For example, EKF Diagnostics recently unveiled its new assay kit for detecting glycated albumin at the American Association for Clinical Chemistry’s 2018 Expo, which provides a highly sensitive marker for albumin analysis through the use of an enzymatic process that analyzes the ration of glycated albumin to albumin in minute samples of blood serums through the assistance of liquid reagents, without any prior preparation. Moreover, the machine is approved by the FDA, and can confirm fluctuations in blood glucose within just 3 weeks in comparison to the tedious wait of conventional methods.
Similarly, Siemens’ Healthineers division unveiled its BN 2 System, which can be used for a wide variety of analysis on protein samples including albumin, with simultaneous operations on more than 100 samples, in conjunction with specialized software for improved automation and data management for more accuracy in clinical interpretation of graphical albumin analyzer results, online data transfer, and algorithmic calculations. The system also boasts of being able to display innovative markers such as lambda and monoclonal kappa free light chains, beta-trace protein, cystatin C, and carbohydrate-deficient transferrin for better healthcare insights for professionals.
Manufacturers Focus on Strategic Partnerships to Improve Market Presence
A number of albumin analyzer producers are emphasizing on boosting the number of sales and boosting their position in the worldwide market through strategic partnerships with different market participants.
For example, Asahi Kasei Pharma signed a comprehensive distribution agreement with Stanbio Laboratory, a subsidiary of EKF Diagnostics Holdings Plc., with the aim of expanding its marketing, promotion, and distribution campaigns for its latest Lucica® Glycated Albumin-L analyzer within the US.
Similarly, Sysmex Corporation of Japan is also collaborating with a number of distributor companies to launch and promote its new UC-3500 Fully-Automated Urine Chemistry Analyzer, for sales in overseas markets.
For more insights on the evolving global albumin analyzers market, click here.